Want to see CRVL full AI Analyst Report?
CRVL Stock Chart & Stats
$72.00
$1.04(0.96%)
At close: 4:00 PM EST
$72.00
$1.04(0.96%)
Day’s Range― - ―
52-Week Range$44.83 - $98.74
Previous CloseN/A
Volume16.34K
Average Volume (3M)163.23K
Market Cap
$3.16B
Enterprise Value$2.74B
Total Cash (Recent Filing)$233.07M
Total Debt (Recent Filing)$28.11M
Price to Earnings (P/E)29.0
Beta0.52
Next Earnings
Aug 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.15
Shares Outstanding51,009,060
10 Day Avg. Volume168,294
30 Day Avg. Volume163,227
Financial Highlights & Ratios
PEG Ratio1.57
Price to Book (P/B)7.11
Price to Sales (P/S)2.92
P/FCF Ratio25.41
Enterprise Value/Market Cap0.87
Enterprise Value/Revenue2.86
Enterprise Value/Gross Profit11.78
Enterprise Value/Ebitda15.70
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthCorVel's conservative capital structure — declining debt (from ~$55M to ~$21M), growing equity and a large cash balance — provides durable financial flexibility to fund technology, payer implementations and M&A. This reduces solvency risk and supports investment through industry cycles.
Revenue Scaling And Margin ExpansionMulti-year revenue scaling coupled with rising operating and net margins demonstrates sustained operating leverage. As the business grows, improved margins indicate scalable processes and pricing power, supporting reinvestment in products and consistent cash generation over the medium term.
Bookings & Enterprise Payer MomentumSubstantially higher new bookings and increased RFP activity signal durable commercial traction and a deeper sales pipeline. Enterprise payer wins and multiyear implementations can create recurring revenue streams and multi-period revenue visibility as implementations scale over months to quarters.
Bears Say
Timing-Related CERIS ContributionsPortions of recent revenue and profit uplift stem from timing-related CERIS recoveries. If such items are nonrecurring, near-term growth and margin comparisons may be overstated, reducing visibility into recurring earnings power and complicating forecasting for the next several quarters.
Elevated Personnel LevelsHigher staffing to support deployments elevates operating expenses until automation and AI productivity gains materialize. Execution risk exists: delayed efficiency improvements would compress margins and slow free cash flow conversion despite stronger top-line momentum.
Industry & Cybersecurity HeadwindsStructural pressures—higher claims severity, rising medical costs, provider access limits—and growing cybersecurity threats raise operating complexity and compliance costs. These trends can increase service delivery costs and require ongoing investment to preserve outcomes and margins.
CorVel News
CRVL FAQ
What was CorVel Corporation’s price range in the past 12 months?
CorVel Corporation lowest stock price was $44.83 and its highest was $98.73 in the past 12 months.
What is CorVel Corporation’s market cap?
CorVel Corporation’s market cap is $3.16B.
When is CorVel Corporation’s upcoming earnings report date?
CorVel Corporation’s upcoming earnings report date is Aug 04, 2026 which is in 18 days.
How were CorVel Corporation’s earnings last quarter?
CorVel Corporation released its earnings results on May 20, 2026. The company reported $0.605 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is CorVel Corporation overvalued?
According to Wall Street analysts CorVel Corporation’s price is currently Overvalued.
Does CorVel Corporation pay dividends?
CorVel Corporation does not currently pay dividends.
What is CorVel Corporation’s EPS estimate?
CorVel Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CorVel Corporation have?
CorVel Corporation has 51,009,060 shares outstanding.
What happened to CorVel Corporation’s price movement after its last earnings report?
CorVel Corporation reported an EPS of $0.605 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 9.249%.
Which hedge fund is a major shareholder of CorVel Corporation?
Currently, no hedge funds are holding shares in CRVL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CorVel Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
CRVL Sentiment 100%
Sector Average 64%
Sector Average 64%
Hedge Fund Trend
Decreased
By 20.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.5M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.16%
12-Months-Change
Fundamentals
Return on Equity
29.92%
Trailing 12-Months
Asset Growth
17.11%
Trailing 12-Months
Company Description
CorVel Corporation
CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims. The company focuses on controlling medical expenditures and ensuring high-quality care across various sectors, including workers' compensation, auto liability, and general health. Leveraging advanced technologies such as artificial intelligence, machine learning, and natural language processing, CorVel enhances the oversight of entire healthcare episodes and their associated costs. Their service portfolio includes a wide array of network solutions, featuring automated medical fee auditing, management and reimbursement for preferred providers, retrospective utilization reviews, and detailed scrutiny of both facility and professional claims. Additionally, they offer pharmacy services, directed care programs, Medicare solutions, clearinghouse functionalities, independent medical examinations, and inpatient medical bill reviews. Beyond network services, CorVel provides a suite of patient management offerings, encompassing claims and case management, round-the-clock nurse triage, utilization management, vocational rehabilitation, and life care planning. The company also processes property and casualty claims specifically for self-insured clients. Established in 1987, CorVel maintains its corporate headquarters in Fort Worth, Texas.
Technical Analysis
Brown & Brown
―
Crawford & Company A
―
Crawford & Company B
―
Baldwin Insurance Group
―
TWFG, Inc. Class A
―
Ownership Overview
38.97% Insiders
12.55% Mutual Funds
0.24% Other Institutional Investors
32.33% Public Companies and
Individual Investors